Multicenter Comparison of Early and Late Vascular Responses to Everolimus-eluting Cobalt-CHromium Stent and Platelet AggregatioN Studies In Patients With Stable Angina Managed as Elective Case : MECHANISM-Elective

Trial Profile

Multicenter Comparison of Early and Late Vascular Responses to Everolimus-eluting Cobalt-CHromium Stent and Platelet AggregatioN Studies In Patients With Stable Angina Managed as Elective Case : MECHANISM-Elective

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 01 Sep 2017

At a glance

  • Drugs Everolimus (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis; Stent thrombosis
  • Focus Therapeutic Use
  • Acronyms MECHANISM-Elective
  • Most Recent Events

    • 29 Aug 2017 Planned End Date changed from 1 Jan 2015 to 31 Dec 2018.
    • 29 Aug 2017 Planned primary completion date changed from 1 Jan 2015 to 31 Dec 2017.
    • 18 Sep 2015 New Source identified and integratED ( University Hospital Medical Information Network - Japan: UMIN000012616 )
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top